NALIA Systems Overview
- Year Founded
-
2005
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Out of Business
NALIA Systems General Information
Description
Developer of an immunodiagnostic system designed to simplify the diagnosis of complex diseases. The company's customizable immunodiagnostic system offers arrays of multiple biomarkers and point-of-care devices, enabling clinicians to improve the diagnosis of complex diseases without increasing healthcare costs.
Contact Information
Website
www.naliasystems.comCorporate Office
- Quest House
- Suite 2 Ground Floor, 125-135 Staines Road
- Hounslow TW3 3JB
- England, United Kingdom
Corporate Office
- Quest House
- Suite 2 Ground Floor, 125-135 Staines Road
- Hounslow TW3 3JB
- England, United Kingdom
NALIA Systems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Out of Business | 22-Oct-2024 | Completed | Out of Business | |||
| 7. Later Stage VC | 08-Dec-2021 | Completed | Generating Revenue | |||
| 6. Angel (individual) | 11-Jun-2018 | Completed | Generating Revenue | |||
| 5. Angel (individual) | 01-Sep-2016 | Completed | Generating Revenue | |||
| 4. Grant | 01-Dec-2015 | Completed | Generating Revenue | |||
| 3. Grant | 05-Jul-2015 | Completed | Generating Revenue | |||
| 2. Grant | 07-May-2015 | $33.1K | Completed | Generating Revenue | ||
| 1. Angel (individual) | 30-Sep-2011 | $33.1K | $33.1K | Completed | Generating Revenue |
NALIA Systems Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 7,800 | $0.001337 | $3.6 | $3.6 | 1x | $3.6 | 6.17% |
NALIA Systems Patents
NALIA Systems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201902305-D0 | Improvements in throughflow immunoassay | Inactive | 20-Feb-2019 | ||
| GB-201615106-D0 | Enhancement of secondary antibody binding in immunoassays | Inactive | 06-Sep-2016 | ||
| GB-201614600-D0 | Improvements in or relating to immunoassays | Inactive | 27-Aug-2016 | ||
| CA-2524928-A1 | Assay method and apparatus | Active | 22-May-2003 | ||
| CA-2524928-C | Assay method and apparatus | Inactive | 22-May-2003 | B01D67/0088 |
NALIA Systems Signals
NALIA Systems FAQs
-
When was NALIA Systems founded?
NALIA Systems was founded in 2005.
-
Where is NALIA Systems headquartered?
NALIA Systems is headquartered in Hounslow, United Kingdom.
-
What is the size of NALIA Systems?
NALIA Systems has 2 total employees.
-
What industry is NALIA Systems in?
NALIA Systems’s primary industry is Diagnostic Equipment.
-
Is NALIA Systems a private or public company?
NALIA Systems is a Private company.
-
What is NALIA Systems’s current revenue?
The current revenue for NALIA Systems is .
-
How much funding has NALIA Systems raised over time?
NALIA Systems has raised $1.07M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process